Pills

This is the text extract for Schedule Update - effective 1 February 2014, browse documents here.


Pharmaceutical Management Agency

Update

New Zealand Pharmaceutical Schedule

Effective 1 February 2014

Cumulative for January and February 2014


Contents

Summary of PHARMAC decisions effective 1 February 2014 ......................... 3 Fluoxetine tender transition .......................................................................... 4 Ferrous sulphate (Ferrograd) tab long-acting 325 mg – fully subsidised ....... 4 Atomoxetine (Strattera) widening of access .................................................. 4 Elemental 028 Extra – pack size change ........................................................ 4 Isosorbide mononitrate long-acting 40 mg tab – change in brand ............... 5 Cellcept (mycophenolate mofetil) – Brand Switch Fee ................................... 5 Dimethicone cream – new listing .................................................................. 5 Folic acid oral liquid supply issue .................................................................. 5 News in brief ................................................................................................. 5 Tender News .................................................................................................. 6 Looking Forward ........................................................................................... 6 Sole Subsidised Supply Products cumulative to February 2014 ..................... 7 New Listings ................................................................................................ 18 Changes to Restrictions, Chemical Names and Presentations ...................... 21 Changes to Subsidy and Manufacturer’s Price............................................. 25 Changes to Section I ................................................................................... 27 Delisted Items ............................................................................................. 28 Items to be Delisted .................................................................................... 30 Index ........................................................................................................... 32

2


Summary of PHARMAC decisions

EFFECTIVE 1 FEBRUARY 2014 New listings (pages 18-20) • Isosorbide mononitrate (Ismo 40 Retard) tab long-acting 40 mg • Dimethicone (healthE Dimethicone 5%) crm 5% pump bottle, 500 ml OP • Dexamethasone phosphate (Dexamethasone-hameln) inj 4 mg per ml, 1 ml ampoule and inj 4 mg per ml, 2 ml ampoule • Baclofen (Lioresal Intrathecal) inj 0.05 mg per ml, 1 ml ampoule and inj 2 mg per ml, 5 ml ampoule – subsidy by endorsement • Fluoxetine hydrochloride (Arrow-Fluoxetine) tab dispersible 20 mg, scored and cap 20 mg • Pharmacy Services (BSF Cellcept) brand switch fee • Oral elemental feed 0.8kcal/ml (Elemental 028 Extra) liquid (grapefruit), 250 ml carton, liquid (pineapple & orange), 250 ml carton and liquid (summer fruit), 250 ml carton,18 OP – Special Authority – Hospital pharmacy [HP3] Changes to restrictions, chemical names and presentation (pages 21-24) • Ferrous sulphate (Ferodan) oral liq 30 mg (6 mg elemental) per 1 ml – amendment to presentation description • Dexamethasone phosphate (Hospira and Dexamethasone-hamelm) inj 4 mg per ml, 1 ml ampoule and inj 4 mg per ml, 2 ml ampoule – amendment to chemical name and presentation description • Oxycodone hydrochloride (Oxydone BNM) tab controlled-release 10 mg, 20 mg, 40 mg and 80 mg – removal of Brand switch fee • Atomoxetine (Strattera) cap 10, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg – amendment to Special Authority • Mycophenolate mofetil (Cellcept) tab 500 mg and cap 250 mg – removal of note – addition of Brand switch fee • Magnesium hydroxide (PSM) paste 29% - amendment to presentation description • Magnesium hydroxide 8% mixture – amendment to Standard Formulae Increase in subsidy (pages 25-26) • Ferrous sulphate (Ferrograd) tab long-acting 325 mg (105 mg elemental) Decreased subsidy (pages 25-26) • Ferrous sulphate (Ferodan) oral liq 30 mg (6 mg elemental) per 1 ml • Compound electrolytes (Electral) powder for oral soln • Urea (Nutraplus) crm 10 % • Oxytocin (Syntocinon) inj 5 iu per ml, 1 ml ampoule and inj 10 iu per ml, 1 ml ampoule • Phenoxymethylpenicillin (penicillin V) (AFT) grans for oral liq 125 mg per 5 ml and grans for oral liq 250 mg per 5 ml • Lamivudine (3TC) tab 150 mg

3


4 Pharmaceutical Schedule - Update News

Fluoxetine tender transition

Arrow-Fluoxetine 20 mg capsules and 20 mg dispersible scored tablets will be listed from 1 February 2014. There will be a subsidy reduction for the Fluox brand from 1 April 2014 and sole supply of the ArrowFluoxetine brand will commence on 1 July 2014. A Brand Switch Fee will apply and patient information leaflets to support the change will be available.

Ferrous sulphate (Ferrograd) tab long-acting 325 mg – fully subsidised

The subsidy for ferrous sulphate (Ferrograd) long-acting 325 mg (105 mg elemental) tablets will be increased and the price reduced resulting in the 30 tablet pack of Ferrograd being fully subsidised from 1 February 2014. There is no change in price or subsidy for Ferrograd long-acting tablets in the 150 tablet pack. This pack size will be delisted from 1 August 2014.

Atomoxetine (Strattera) widening of access

From 1 February 2014, the Special Authority criteria for atomoxetine (Strattera) capsules will be widened to include its first-line use for Attention Deficit and Hyperactivity Disorder (ADHD) in patients with a history of psychoses or who have a first-degree relative with schizophrenia.

Elemental 028 Extra – pack size change

Elemental 028 Extra liquid will be listed in packs of 18 cartons of 250 ml from 1 February 2014 to meet food labelling requirements. The 18 carton pack size will be listed as an Original Pack (OP). The single carton packs will be delisted 1 August 2014. These changes apply to all flavours (grapefruit, pineapple & orange, and summer fruits).


Pharmaceutical Schedule - Update News

5

Isosorbide mononitrate long-acting 40 mg tab – change in brand

The Ismo 40 Retard brand of isosorbide mononitrate 40 mg long-acting tablets will be listed from 1 February 2014. Also from this date, the sole supply for the Corangin brand of 40 mg long-acting tablets will be suspended. The Corangin brand will be delisted on 1 August 2014.

Cellcept (mycophenolate mofetil) – Brand Switch Fee

A Brand Switch Fee will apply to dispensings of the Cellcept brand of mycophenolate mofetil 250 mg tablets and 500 mg capsules from 1 February 2014 until 1 May 2014.

Dimethicone cream – new listing

The healthE brand of dimethicone 5% cream in a 500 ml pump bottle OP will be listed from 1 February 2014. This presentation is to be dispensed three months all-at-once.

Folic acid oral liquid supply issue

There is a potential stock supply issue of Biomed’s folic acid oral liquid 50 mcg per ml. Pharmacists are advised to dispense tablets where appropriate.

News in brief

• The 28 suppository pack of Pentasa (mesalazine) suppos 1 g will be delisted from 1 August 2014. The 30 suppository pack of Pentasa (mesalazine) suppos 1 g will remain listed. • Batrafen (ciclopirox olamine) soln 1%, 20 ml OP will be delisted from 1 August 2014. Ciclopirox olamine nail-solution 8% will remain listed. • Baclofen (Lioresal Intrathecal) inj 0.05 mg per ml, 1 ml ampoule and inj 2 mg per ml, 5 ml ampoule will be listed fully subsidised subject to endorsement from 1 February 2014. • Transfer of Sole Subsidised Supply of spironolactone 25 mg tablets from Spirotone to Spiractin from 1 February 2014.


Tender News

Sole Subsidised Supply changes – effective 1 March 2014

Chemical Name Clopidogrel Loratadine Morphine sulphate Morphine sulphate Morphine sulphate Morphine sulphate Tamsulosin hydrochloride Presentation; Pack size Tab 75 mg; 84 tab Tab 10 mg; 100 tab Cap long-acting 10 mg; 10 cap Cap long-acting 30 mg; 10 cap Cap long-acting 60 mg; 10 cap Cap long-acting 100 mg; 10 cap Cap 400 mcg; 100 cap Sole Subsidised Supply brand (and supplier) Arrow - Clopid (Arrow) Lorafix (Arrow) m-Eslon (Multichem) m-Eslon (Multichem) m-Eslon (Multichem) m-Eslon (Multichem) Tamsulosin-Rex (Rex Medical Ltd)

Looking Forward

This section is designed to alert both pharmacists and prescribers to possible future changes to the Pharmaceutical Schedule. It may also assist pharmacists, distributors and wholesalers to manage stock levels. Possible decisions for future implementation 1 March 2014 • Pantoprazole (Pantoprazole Actavis 20) tab EC 20 mg and pantoprazole (Pantoprazole Actavis 40) tab EC 40 mg – new listing

6


Sole Subsidised Supply Products – cumulative to February 2014

Generic Name

Abacavir sulphate Acarbose Acetazolamide Acetylcysteine Aciclovir Allopurinol Amantadine hydrochloride Aminophylline Amiodarone hydrochloride Amisulpride Amitriptyline Amlodipine Amoxycillin Amoxycillin clavulanate

Presentation

Oral liq 20 mg per ml Tab 300 mg Tab 50 mg and 100 mg Tab 250 mg Inj 200 mg per ml, 10 ml Tab dispersible 200 mg, 400 mg & 800 mg Tab 100 mg & 300 mg Cap 100 mg Inj 25 mg per ml, 10 ml Inj 50 mg per ml, 3 ml ampoule Oral liq 100 mg per ml Tab 100 mg, 200 mg & 400 mg Tab 10 mg Tab 25 mg & 50 mg Tab 2.5 mg Tab 5 mg & 10 mg Inj 250 mg, 500 mg & 1 g Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml Tab 500 mg with potassium clavulanate 125 mg Crm Tab 100 mg Tab 50 mg & 100 mg Tab 10 mg, 20 mg, 40 mg & 80 mg Inj 600 mcg, 1 ml Tab 500 mg Tab 10 mg Tab 2.5 mg & 5 mg Inj 1.2 mega u per 2.3 ml Inj 600 mg Eye drops 0.5% Eye drops 0.25%

Brand Name Expiry Date*

Ziagen Ziagen Accarb Diamox Martindale Acetylcysteine Lovir Apo-Allopurinol Symmetrel DBL Aminophylline Cordarone-X Solian Arrow-Amitriptyline Amitrip Apo-Amlodipine Apo-Amlodipine Ibiamox Augmentin Augmentin Curam Duo AFT Cvite Mylan Atenolol Zarator AstraZeneca Apo-Azithromycin Pacifen ArrowBendrofluazide Bicillin LA Sandoz Betoptic Betoptic S 2014 2014 2016 2015 2015 2015 2015 2016 2014 2015 2014 2014 2014 2015 2014 2015 2016 2014 2014 2014 2016 2016 2014 2014 2014 2015

Aqueous cream Ascorbic acid Atenolol Atorvastatin Atropine sulphate Azithromycin Baclofen Bendrofluazide Benzathine benzylpenicillin Benzylpenicillin sodium (Penicillin G) Betaxolol hydrochloride

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

7


Sole Subsidised Supply Products – cumulative to February 2014

Generic Name

Bezafibrate Bicalutamide Blood glucose diagnostic test meter Blood glucose diagnostic test strip Boceprevir Brimonidine tartrate Bupropion hydrochloride Cabergoline Calamine Calcitonin Calcium carbonate Calcium folinate Candesartan Carbomer Cefaclor monohydrate Cefalexin monohydrate

Presentation

Tab 200 mg Tab long-acting 400 mg Tab 50 mg Meter with 50 lancets, a lancing device and 10 diagnostic test strips Blood glucose test strips Cap 200 mg Eye drops 0.2% Tab modified-release 150 mg Tab 0.5 mg Lotn, BP Inj 100 iu per ml, 1 ml Tab 1.25 g (500 mg elemental) Tab eff 1.75 g (1 g elemental) Tab 15 mg Tab 4 mg, 8 mg, 16 mg & 32 mg Ophthalmic gel 0.3%, 0.5 g Cap 250 mg Grans for oral liq 125 mg per 5 ml Cap 500 mg Grans for oral liq 125 mg per 5 ml & 250 mg per 5 ml Inj 500 mg & 1 g Inj 750 mg Oral liq 1 mg per ml Tab 10 mg Eye oint 1% Eye drops 0.5% Mouthwash 0.2% Handrub 1% with ethanol 70% Soln 4% Nail-soln 8% Tab 0.5 mg, 2.5 mg & 5 mg Tab 250 mg, 500 mg & 750 mg Tab 20 mg Tab 500 mg Tab 250 mg

Brand Name Expiry Date*

Bezalip Bezalip Retard Bicalaccord CareSens N CareSens N POP CareSens II CareSens CareSens N Victrelis Arrow-Brimonidine Zyban Dostinex PSM Miacalcic Arrow-Calcium Calsource DBL Leucovorin Calcium Candestar Poly-Gel Ranbaxy-Cefaclor Cephalexin ABM Cefalexin Sandoz AFT Multichem Cetirizine - AFT Zetop Chlorsig Chlorafast healthE healthE Orion Apo-Ciclopirox Zapril Cipflox Arrow-Citalopram Apo-Clarithromycin Apo-Clarithromycin 2015 2014 2015

2015 2016 2014 2016 2015 2015 2014 2014 2014 2015 2016 2016 2016 2015 2014 2014 2014 2015 2015 2014 2015 2016 2014 2014 2014

Cefazolin sodium Cefuroxime sodium Cetirizine hydrochloride Chloramphenicol Chlorhexidine gluconate

Ciclopirox olamine Cilazapril Ciprofloxacin Citalopram hydrobromide Clarithromycin

8

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to February 2014

Generic Name

Clindamycin Clomiphene citrate Clomipramine hydrochloride Clonidine hydrochloride

Presentation

Cap hydrochloride 150 mg Inj phosphate 150 mg per ml, 4 ml Tab 50 mg Tab 10 mg & 25 mg Tab 25 mcg Tab 150 mcg Inj 150 mcg per ml, 1 ml Vaginal crm 1% with applicators Vaginal crm 2% with applicators Crm 1% Tab 15 mg, 30 mg & 60 mg Tab 500 mcg Crm 10% Tab 50 mg Oral liq 100 mg per ml Tab 50 mg & 100 mg Tab 2 mg with ethinyloestradiol 35 mcg and 7 inert tabs Nasal spray 10 mcg per dose Tab 1 mg & 4 mg Eye oint 0.1%

Brand Name Expiry Date*

Clindamycin ABM Dalacin C Serophene Apo-Clomipramine Clonidine BNM Catapres Clomazol Clomazol PSM Colgout Itch-Soothe Nausicalm Neoral Siterone Ginet 84 Desmopressin-PH&T Douglas Maxidex Maxitrol Maxitrol 2016 2016 2015 2015

Clotrimazole

2016 2014 2016 2016 2015 2015 2015 2015 2014 2014 2015 2014 2014

Codeine phosphate Colchicine Crotamiton Cyclizine hydrochloride Cyclosporin Cyproterone acetate Cyproterone acetate with ethinyloestradiol Desmopressin Dexamethasone

Dexamethasone with neomycin Eye oint 0.1% with neomycin sulphate and polymyxin b sulphate 0.35% and polymyxin B sulphate 6,000 u per g Eye drops 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per ml Dexamphetamine sulphate Dextrose Dextrose with electrolytes Diclofenac sodium Tab 5 mg Inj 50%, 10 ml Soln with electrolytes; 1,000 ml OP Tab EC 25 mg & 50 mg Tab long-acting 75 mg & 100 mg Inj 25 mg per ml, 3 ml Eye drops 1 mg per ml Suppos 12.5 mg, 25 mg, 50 mg & 100 mg Tab long-acting 60 mg Cap long-acting 180 mg & 240 mg Tab 30 mg & 60 mg Tab long-acting 150 mg Cap 50 mg Cap 120 mg

PSM Biomed Pedialyte-Bubblegum Apo-Diclo Diclax SR Voltaren Voltaren Ophtha Voltaren DHC Continus Apo-Diltiazem CD Dilzem Pytazen SR Laxofast 50 Laxofast 120

2015 2014 2016 2015 2014

Dihydrocodeine tartrate Diltiazem hydrochloride Dipyridamole Docusate sodium

2016 2015 2014 2014

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

9


Sole Subsidised Supply Products – cumulative to February 2014

Generic Name

Domperidone Doxazosin mesylate Doxycycline hydrochloride Emulsifying ointment Enoxaparin sodium Entacapone Ergometrine maleate Etidronate disodium Ethinyloestradiol Ethinyloestradiol with levonorgestrel

Presentation

Tab 10 mg Tab 2 mg & 4 mg Tab 100 mg Oint BP Inj 20 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg & 150 mg Tab 200 mg Inj 500 mcg per ml, 1 ml Tab 200 mg Tab 10 mcg Tab 20 mcg with levonorgestrel 100 mcg & 7 inert tab Tab 30 mcg with levonorgestrel 150 mcg & 7 inert tab Tab 25 mg Tab long-acting 5 mg & 10 mg Tab long-acting 2.5 mg Inj 50 mcg per ml, 2 ml & 10 ml Inj 300 mcg per 0.5 ml Inj 480 mcg per 0.5 ml Tab 5 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap 250 mg & 500 mg Inj 250 mg, 500 mg & 1 g Cap 50 mg, 150 mg & 200 mg Eye drops 0.1% Crm 5% Metered aqueous nasal spray, 50 mcg per dose Tab 500 mg Tab 40 mg Oint 2% Tab 600 mg Inj 40 mg per ml, 2 ml Tab 80 mg Tab 5 mg Suppos 3.6 g

Brand Name Expiry Date*

Prokinex Apo-Doxazosin Doxine AFT Clexane Entapone DBL Ergometrine Arrow-Etidronate NZ Medical and Scientific Ava 20 ED Ava 30 ED Aromasin Plendil ER Plendil ER Boucher and Muir Zarzio Zarzio Rex Medical AFT Staphlex Flucloxin Ozole Flucon Efudix Flixonase Hayfever & Allergy Urex Forte Diurin 40 Foban Lipazil Pfizer Apo-Gliclazide Minidiab PSM 2014 2015 2015

31/12/15

2015 2014 2014 2014 2015 2015 2014 2015 2015 2014

Exemestane Felodopine Fentanyl Filgrastim Finasteride Flucloxacillin sodium

2014 2015 2014 2014 2015 2015 2015 2015 2016 2016 2015 2014 2015 2015

Fluconazole Fluorometholone Fluorouracil sodium Fluticasone propionate Furosemide Fusidic acid Gemfibrozil Gentamicin sulphate Gliclazide Glipizide Glycerol

10

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to February 2014

Generic Name

Glyceryl trinitrate

Presentation

Aerosol spray 400 mcg per dose TDDS 5 mg & 10 mg Tab 600 mcg Tab 500 mcg, 1.5 mg & 5 mg Oral liq 2 mg per ml Inj 5 mg per ml, 1 ml Inj 100 mg vial Tab 5 mg & 20 mg Crm 1% Powder Rectal foam 10%, CFC-Free (14 applications) Lipocream 0.1% Milky emul 0.1% Oint 0.1% Scalp lotn 0.1% Lotn 1% with wool fat hydrous 3% and mineral oil Inj 1 mg per ml, 1 ml Tab 200 mg Patch 1.5 mg Inj 20 mg, 1 ml Tab 10 mg Tab 200 mg Tab long-acting 800 mg Crm 5% Tab 2.5 mg Nebuliser soln, 250 mcg per ml, 1 ml Nebuliser soln, 250 mcg per ml, 2 ml Inj 50 mg per ml, 2 ml Tab 100 mg Tab 20 mg Cap 10 mg & 20 mg Powder for oral soln Cap 100 mg Shampoo 2% Oral liq 10 mg per ml; 240 ml OP Tab 100 mg Cap 15 mg & 30 mg Eye drops 50 mcg per ml

Brand Name Expiry Date*

Glytrin Nitroderm TTS Lycinate Serenace 2014

Haloperidol

2016

Hydrocortisone

Solu-Cortef Douglas Pharmacy Health ABM Colifoam Locoid Lipocream Locoid Crelo Locoid Locoid DP Lotn HC ABM Hydroxocobalamin Plaquenil Scopoderm TTS Buscopan Gastrosoothe Arrowcare Brufen SR Aldara Dapa-Tabs Univent Ferrum H PSM Ismo 20 Oratane Konsyl-D Itrazole Sebizole 3TC Zetlam Solox Hysite

2016 2015 2014 2015 2015

Hydrocortisone acetate Hydrocortisone butyrate

Hydrocortisone with wool fat and mineral oil Hydroxocobalamin Hydroxychloroquine sulphate Hyoscine hydrobromide Hyoscine N-butylbromide Ibuprofen Imiquimod Indapamide Ipratropium bromide Iron polymaltose Isoniazid Isosorbide mononitrate Isotretinoin Ispaghula (psyllium) husk Itraconazole Ketoconazole Lamivudine Lansoprazole Latanoprost

2014 2015 2015 2016 2014 2014 2014 2016 2016 2014 2015 2014 2015 2016 2016 2014 2016 2014 2015 2015

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

11


Sole Subsidised Supply Products – cumulative to February 2014

Generic Name

Letrozole Levonorgestrel Lidocaine [lignocaine] hydrochloride Lisinopril Lithium carbonate Lodoxamide trometamol Losartan Losartan with hydrochlorothiazide Macrogol Macrogol 400 and propylene glycol Mask for spacer device Mebendazole Mebeverine hydrochloride Medroxyprogesterone acetate Megestrol acetate Methotrexate Methylprednisolone Methylprednisolone acetate Methylprednisolone acetate with lignocaine Mesalazine Metformin hydrochloride Methadone hydrochloride

Presentation

Tab 2.5 mg Tab 1.5 mg Inj 2% ampoule, 5 ml & 20 ml Viscous soln 2% Tab 5 mg, 10 mg & 20 mg Tab 250 mg & 400 mg Cap 250 mg Eye drops 0.1% Tab 12.5 mg, 25 mg, 50 mg & 100 mg Tab 50 mg with hydrochlorothiazide 12.5 mg Powder 13.125 g, sachets Eye drops 0.4% and propylene glycol 0.3%, 0.4 ml Size 2 Tab 100 mg Tab 135 mg Tab 2.5 mg, 5 mg, 10 mg & 100 mg Inj 150 mg per ml, 1 ml syringe Tab 160 mg Inj 25 mg per ml, 2 ml & 20 ml Tab 4 mg & 100 mg Inj 40 mg per ml Inj 40 mg per ml with lignocaine 1 ml Enema 1 g per 100 ml Suppos 500 mg Tab immediate-release 500 mg & 850 mg Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Inj prefilled syringe 7.5 mg, 10 mg, 15 mg, 20 mg, 25 mg & 30 mg Inj 40 mg per ml, 1 ml; 62.5 mg per ml, 2 ml; 500 mg & 1 g Inj 5 mg per ml, 2 ml Tab 10 mg

Brand Name Expiry Date*

Letraccord Postinor-1 Lidocaine-Claris Xylocaine Viscous Arrow-Lisinopril Lithicarb FC Douglas Lomide Lostaar Arrow-Losartan & Hydroclorothiazide Lax-Sachets Systane Unit Dose EZ-fit Paediatric Mask De-Worm Colofac Provera Depo-Provera Apo-Megestrol Hospira Medrol Depo-Medrol Depo-Medrol with Lidocaine Pentasa Asacol Apotex Biodone Biodone Forte Biodone Extra Forte Methotrexate Sandoz Solu-Medrol Pfizer Metamide 2015 2016 2015 2014 2015 2015 2014 2014 2014 2014 2014 2016 2015 2014 2014 2016 2015 2016 2015 2015 2015 2015 2014 2015 2015

Methotrexate Methylprednisolone sodium succinate Metoclopramide hydrochloride

2016 2015 2014

12

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to February 2014

Generic Name

Metoprolol succinate Metoprolol tartrate

Presentation

Tab long-acting 23.75 mg, 47.5 mg, 95 mg & 190 mg Inj 1 mg per ml, 5 ml Tab 50 mg & 100 mg Tab long-acting 200 mg Tab 50 mg Oral gel 20 mg per g Crm 2% Tab 30 mg & 45 mg Inj 5 mg vial Tab 150 mg & 300 mg Crm 0.1% Oint 0.1% Oral liq 1 mg per ml, 2 mg per ml, 5 mg per ml & 10 mg per ml Tab long-acting 10 mg, 30 mg, 60 mg & 100 mg Inj 5 mg per ml, 1 ml Inj 10 mg per ml, 1 ml Inj 15 mg per ml, 1 ml Inj 30 mg per ml, 1 ml

Brand Name Expiry Date*

Metoprolol-AFT CR Lopresor Lopresor Slow-Lopresor Puri-nethol Decozol Multichem Avanza Arrow Apo-Moclobemide m-Mometasone RA-Morph Arrow-Morphine LA DBL Morphine Sulphate DBL Morphine Sulphate DBL Morphine Sulphate DBL Morphine Sulphate Hospira Cellcept Naltraccord Naphcon Forte Apo-Nadolol Noflam 250 Noflam 500 AstraZeneca Nevirapine Alphapharm Habitrol Habitrol Habitrol Apo-Nicotinic Acid Noriday 28 Primolut N 2014 2015 2014 2015 2015

Mercaptopurine Miconazole Miconazole nitrate Mirtazapine Mitomycin C Moclobemide Mometasone furoate Morphine hydrochloride Morphine sulphate

2016 2015 2014 2015 2016 2015 2015 2015 2016 2014

Morphine tartrate Mycophenolate mofetil Naltrexone hydrochloride Naphazoline hydrochloride Nadolol Naproxen Neostigmine Nevirapine Nicotine

Inj 80 mg per ml, 1.5 ml & 5 ml Cap 250 mg Tab 500 mg Tab 50 mg Eye drops 0.1% Tab 40 mg & 80 mg Tab 250 mg Tab 500 mg Inj 2.5 mg per ml, 1 ml Tab 200 mg Gum 2 mg & 4 mg (classic, fruit, mint) Lozenge 1 mg & 2 mg Patch 7 mg, 14 mg & 21 mg Tab 50 mg & 500 mg Tab 350 mcg Tab 5 mg

2016 2016 2016 2014 2015 2015 2014 2015 2014

Nicotinic acid Norethisterone

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

13


Sole Subsidised Supply Products – cumulative to February 2014

Generic Name

Norfloxacin Nortriptyline hydrochloride Nystatin Octreotide (somatostatin analogue) Oil in water emulsion Omeprazole

Presentation

Tab 400 mg Tab 10 mg & 25 mg Oral liq 100,000 u per ml Inj 50 mcg per ml, 1 ml Inj 100 mcg per ml, 1 ml Inj 500 mcg per ml, 1 ml Crm Cap 10 mg, 20 mg & 40 mg Powder Inj 40 mg Tab 10 mg & 15 mg Oral liq 5 mg per ml Tab 5 mg Tab controlled-release 10 mg, 20 mg, 40 mg & 80 mg Inj 50 mg per ml, 1 ml Inj 10 mg per ml, 1 ml & 2 ml Inj 5 iu with ergometrine maleate 500 mcg per ml, 1 ml Inj 3 mg per ml, 10 ml; 6 mg per ml, 10 ml & 9 mg per ml, 10 ml Inj 40 mg Suppos 500 mg Tab 500 mg Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml Tab paracetamol 500 mg with codeine phosphate 8 mg Low range & normal range Inj 135 mcg prefilled syringe & inj 180 mcg prefilled syringe Inj 135 mcg prefilled syringe × 4 with ribavirin tab 200 mg × 112 Inj 135 mcg prefilled syringe × 4 with ribavirin tab 200 mg × 168 Inj 180 mcg prefilled syringe × 4 with ribavirin tab 200 mg × 112 Inj 180 mcg prefilled syringe × 4 with ribavirin tab 200 mg × 168

Brand Name Expiry Date*

Arrow-Norfloxacin Norpress Nilstat Octreotide Max Rx 2014 2016 2014 2014

healthE Fatty Cream Omezol Relief Midwest Dr Reddy’s Omeprazole Ox-Pam Apo-Oxybutynin Oxydone BNM OxyNorm Oxycodone Orion Syntometrine Pamidronate BNM Pantocid IV Paracare Parafast Ethics Paracetamol Paracare Double Strength Paracetamol + Codeine (Relieve) Breath-Alert Pegasys Pegasys RBV Combination Pack Pegasys RBV Combination Pack Pegasys RBV Combination Pack Pegasys RBV Combination Pack

2015 2014

Oxazepam Oxybutynin Oxycodone hydrochloride

2014 2016 2015

Oxytocin Pamidronate disodium Pantoprazole Paracetamol

2015 2014 2014 2015 2014

Paracetamol with codeine Peak flow meter Pegylated interferon alfa-2a Pegylated interferon alfa-2a

2014 2015 2017 2017

14

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to February 2014

Generic Name

Pergolide Permethrin Pethidine hydrochloride

Presentation

Tab 0.25 mg & 1 mg Crm 5% Lotn 5% Tab 50 mg & 100 mg Inj 50 mg per ml, 1 ml Inj 50 mg per ml, 2 ml

Brand Name Expiry Date*

Permax Lyderm A-Scabies PSM DBL Pethidine Hydrochloride DBL Pethidine Hydrochloride PSM Apo-Pindolol Pizaccord Sandomigran Coloxyl Span-K Cholvastin Cilicaine Allersoothe Allersoothe Mestinon PyridoxADE Apo-Pyridoxine Arrow-Quinapril Accuretic 10 Accuretic 20 Peptisoothe Arrow-Ranitidine Mycobutin Norvir Rizamelt ArrowRoxithromycin Asthalin Duolin 2014 2016 2015 2014 2015 2015 2015 2014 2014 2015 2014

Phenobarbitone Pindolol Pioglitazone Pizotifen Poloxamer Potassium chloride Pravastatin Procaine penicillin Promethazine hydrochloride Pyridostigmine bromide Pyridoxine hydrochloride Quinapril Quinapril with hydrochlorothiazide

Tab 15 mg & 30 mg Tab 5 mg, 10 mg & 15 mg Tab 15 mg, 30 mg & 45 mg Tab 500 mcg Oral drops 10% Tab long-acting 600 mg Tab 20 mg & 40 mg Inj 1.5 mega u Oral liq 5 mg per 5 ml Tab 10 mg & 25 mg Tab 60 mg Tab 25 mg Tab 50 mg Tab 5 mg, 10 mg & 20 mg Tab 10 mg with hydrochlorothiazide 12.5 mg Tab 20 mg with hydrochlorothiazide 12.5 mg Oral liq 150 mg per 10 ml Tab 150 mg & 300 mg Cap 150 mg Tab 100 mg Tab orodispersible 10 mg Tab 150 mg & 300 mg Nebuliser soln, 1 mg per ml & 2 mg per ml, 2.5 ml Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per vial, 2.5 ml Tab 50 mg & 100 mg Tab 25 mg, 50 mg & 100 mg

2015 2016 2015 2015 2014 2015 2014 2014 2015 2014 2014 2015 2015

Ranitidine hydrochloride Rifabutin Ritonavir Rizatriptan Roxithromycin Salbutamol Salbutamol with ipratropium bromide Sertraline Sildenafil

Arrow-Sertraline Silagra

2016 2014

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

15


Sole Subsidised Supply Products – cumulative to February 2014

Generic Name

Simvastatin

Presentation

Tab 10 mg Tab 20 mg Tab 40 mg Tab 80 mg Inj 23.4%, 20 ml ampoule Enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml Eye drops 1 mg per ml, 10 ml OP 800 ml 230 ml (single patient) Tab 25 mg Tab 100 mg Tab 500 mg Tab EC 500 mg Tab 50 mg & 100 mg Inj 12 mg per ml, 0.5 ml cartridge Tab 20 mg Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium, 500 ml & 1,000 ml Tab 10 mg Cap 5 mg, 20 mg, 100 mg & 250 mg Tab 1 mg, 2 mg & 5 mg Tab 250 mg Inj long-acting 100 mg per ml, 10 ml Cap 40 mg Tab 25 mg Inj 250 mcg per ml, 1 ml ampoule Inj 1 mg per ml, 1 ml Eye drops 0.25% & 0.5% Eye drops 0.3% Eye oint 0.3% Inj 40 mg per ml, 2 ml Tab 100 mg Cap 50 mg Crm 0.5 mg per g

Brand Name Expiry Date*

Arrow-Simva 10mg Arrow-Simva 20mg Arrow-Simva 40mg Arrow-Simva 80mg Biomed Micolette Hylo-Fresh Volumatic Space Chamber Plus Spiractin Spirotone Salazopyrin Salazopyrin EN Arrow-Sumatriptan Genox Pinetarsol 2014

Sodium chloride Sodium citrate with sodium lauryl sulphoacetate Sodium hyaluronate Spacer device Spironolactone Sulphasalazine Sumatriptan Tamoxifen citrate Tar with triethanolamine lauryl sulphate and fluorescein Temazepam Temozolomide Terazosin Terbinafine Testosterone cypionate Testosterone undecanoate Tetrabenazine Tetracosactrin Timolol maleate Tobramycin

2016 2016 2016 2015 2016 2016 2016 2014 2014

Normison Temaccord Arrow Dr Reddy’s Terbinafine Depo-Testosterone Andriol Testocaps Motetis Synacthen Synacthen Depot Arrow-Timolol Tobrex Tobrex DBL Tobramycin Tasmar Arrow-Tramadol ReTrieve

2014 2016 2016 2014 2014 2015 2016 2014 2014 2014

Tolcapone Tramadol hydrochloride Tretinoin

2014 2014 2016

16

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to February 2014

Generic Name

Triamcinolone acetonide

Presentation

Inj 10 mg per ml, 1 ml Inj 40 mg per ml, 1 ml Crm 0.02% Oint 0.02% 0.1% in Dental Paste USP Eye drops 0.5% & 1% Cap 250 mg Inj 500 mg Tab 40 mg & 80 mg Tab, strong, BPC Tab (BCP cap strength) Cap 100 mg & oral liq 10 mg per ml Tab 300 mg with lamivudine 150 mg Oint BP Caps 137.4 mg (50 mg elemental)

Brand Name Expiry Date*

Kenacort-A Kenacort-A40 Aristocort Aristocort Oracort Mydriacyl Ursosan Mylan Isoptin Bplex Mvite Retrovir Alphapharm Multichem Zincaps 2014

Tropicamide Ursodeoxycholic acid Vancomycin hydrochloride Verapamil hydrochloride Vitamin B complex Vitamins Zidovudine [AZT] Zidovudine [AZT] with lamivudine Zinc and castor oil Zinc sulphate February changes are in bold type

2014 2014 2014 2014 2016 2016 2016 2014 2014 2014

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

17


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 February 2014

61 70 ISOSORBIDE MONONITRATE ❋ Tab long-acting 40 mg .............................................................. 7.50 DIMETHICONE ❋ Crm 5% pump bottle .................................................................. 4.73 DEXAMETHASONE PHOSPHATE Dexamethasone phosphate injection will not be funded for oral use. ❋ Inj 4 mg per ml, 1 ml ampoule – Up to 5 inj available on a PSO ........................................... 25.80 ❋ Inj 4 mg per ml, 2 ml ampoule – Up to 5 inj available on a PSO ........................................... 17.98 BACLOFEN Inj 0.05 mg per ml, 1 ml ampoule - Subsidy by endorsement ... 11.55 30 ✔ Ismo 40 Retard

500 ml OP ✔ healthE Dimethicone 5%

82

10 5

✔ Dexamethasonehameln ✔ Dexamethasonehameln ✔ Lioresal Intrathecal

121

1

Subsidised only for use in a programmable pump in patients where oral antispastic agents have been ineffective or have caused intolerable side effects and the prescription is endorsed accordingly. Inj 2 mg per ml, 5 ml ampoule - Subsidy by endorsement ...... 209.29 1 ✔ Lioresal Intrathecal Subsidised only for use in a programmable pump in patients where oral antispastic agents have been ineffective or have caused intolerable side effects and the prescription is endorsed accordingly.

129

FLUOXETINE HYDROCHLORIDE ❋ Tab dispersible 20 mg, scored – Subsidy by endorsement ......... 2.50

30

✔ Arrow-Fluoxetine

192

Subsidised by endorsement 1) When prescribed for a patient who cannot swallow whole tablets or capsules and the prescription is endorsed accordingly; or 2) When prescribed in a daily dose that is not a multiple of 20 mg in which case the prescription is deemed to be endorsed. Note: Tablets should be combined with capsules to facilitate incremental 10 mg doses. ❋ Cap 20 mg ................................................................................ 1.74 90 ✔ Arrow-Fluoxetine PHARMACY SERVICES – May only be claimed once per patient ❋ Brand switch fee........................................................................ 4.33 The Pharmacode for the BSF Cellcept is 2452189. 1 fee ✔ BSF Cellcept

208

ORAL ELEMENTAL FEED 0.8 KCAL/ML – Special Authority see SA1377 – Hospital pharmacy [HP3] Liquid (grapefruit), 250 ml carton .......................................... 171.00 18 OP ✔ Elemental 028 Extra Liquid (pineapple & orange), 250 ml carton............................ 171.00 18 OP ✔ Elemental 028 Extra Liquid (summer fruit), 250 ml carton ..................................... 171.00 18 OP ✔ Elemental 028 Extra

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

18

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings – effective 1 January 2014

37 PANCREATIC ENZYME Cap EC 25,000 BP u lipase, 18,000 BP u amylase, 1,000 BP u protease ............................................................ 94.38 100 ✔ Creon 25000

45

ELTROMBOPAG – Special Authority see SA1412 – Retail pharmacy – Wastage claimable Tab 25 mg ......................................................................... 1,771.00 28 ✔ Revolade Tab 50 mg ......................................................................... 3,542.00 28 ✔ Revolade ➽ SA1412 Special Authority for Subsidy Initial application - (idiopathic thrombocytopenic purpura – post-splenectomy) only from a haematologist. Approvals valid for 6 weeks for applications meeting the following criteria: All of the following: 1. Patient has had a splenectomy; and 2. Two immunosuppressive therapies have been trialled and failed after therapy of 3 months each (or 1 month for rituximab); and 3. Either: 3.1. Patient has a platelet count of ≤20,000 platelets per microlitre and has evidence of active bleeding; or 3.2. Patient has a platelet count of ≤10,000 platelets per microlitre. Initial application - (idiopathic thrombocytopenic purpura – preparation for splenectomy) only from a haematologist. Approvals valid for 6 weeks where the patient requires eltrombopag treatment as preparation for splenectomy. Renewal– (idiopathic thrombocytopenic purpura – post-splenectomy) from a haematologist. Approvals valid for 12 months where the patient has obtained a response (see Note) from treatment during the initial approval or subsequent renewal periods and further treatment is required. Note: Response to treatment is defined as a platelet count of >30,000 platelets per microlitre.

53

CILAZAPRIL WITH HYDROCHLOROTHIAZIDE ❋ Tab 5 mg with hydrochlorothiazide 12.5 mg............................. 10.72 DILTIAZEM HYDROCHLORIDE Cap long-acting 120 mg ............................................................ 1.91 ACIPIMOX ❋ Cap 250 mg ............................................................................ 18.75 CARBIMAZOLE Tab 5 mg ................................................................................ 10.80

100

✔ Apo-Cilazapril/ Hydrochlorothiazide ✔ Cardizem CD ✔ Olbetam s29 S29

57 60 86 90

30 30 100

✔ AFT S29

CEFTRIAXONE – Subsidy by endorsement a) Up to 5 inj available on a PSO b) Subsidised only if prescribed for a dialysis or cystic fibrosis patient, or the treatment of gonorrhoea, or the treatment of pelvic inflammatory disease, or the treatment of suspected meningitis in patients who have a known allergy to penicillin, and the prescription or PSO is endorsed accordingly. Inj 500 mg vial .......................................................................... 1.50 1 ✔ Ceftriaxone-AFT Inj 1 g vial ................................................................................. 5.22 5 ✔ Ceftriaxone-AFT AMOXYCILLIN Cap 250 mg ............................................................................ 16.18 a) Up to 30 cap available on a PSO b) Up to 10 x the maximum PSO quantity for RFPP – see rule 5.2.6 500 ✔ Apo-Amoxi

92

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

19


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings – effective 1 January 2014 (continued)

187 PHARMACY SERVICES - May only be claimed once per patient ❋ Brand switch fee........................................................................ 4.33 The Pharmacode for BSF Oxydone BNM is 2451794. 1 fee ✔ BSF Oxydone BNM

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

20

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions, Chemical Names and Presentations

Effective 1 February 2014

42 FERROUS SULPHATE (amendment to presentation description) ❋‡ Oral liq 30 mg (6 mg elemental) per 1 ml (6 mg elemental per 1 ml) ................................................... 10.28

500 ml

✔ Ferodan

82

DEXAMETHASONE SODIUM PHOSPHATE (amendment to chemical name and presentation description) Dexamethasone sodium phosphate injection will not be funded for oral use. ❋ Inj 4 mg per ml, 1 ml ampoule – Up to 5 inj available on a PSO ........................................... 25.80 10 ✔ Dexamethasonehameln 21.50 5 ✔ Hospira ❋ Inj 4 mg per ml, 2 ml ampoule – Up to 5 inj available on a PSO ........................................... 17.98 5 ✔ Dexamethasonehameln 31.00 ✔ Hospira OXYCODONE HYDROCHLORIDE (removal of Brand switch fee) a) Only on a controlled drug form b) See prescribing guideline c) No patient co-payment payable d) Safety medicine; prescriber may determine dispensing frequency Tab controlled-release 10 mg – Brand switch fee payable (Pharmacode 2451794) .............. 6.75 Tab controlled-release 20 mg – Brand switch fee payable (Pharmacode 2451794) ............ 11.50 Tab controlled-release 40 mg – Brand switch fee payable (Pharmacode 2451794) ............ 18.50 Tab controlled-release 80 mg – Brand switch fee payable (Pharmacode 2451794) ........... 34.00 ATOMOXETINE – Special Authority see SA14160951 – Retail pharmacy Cap 10 mg ............................................................................ 107.03 Cap 18 mg ............................................................................ 107.03 Cap 25 mg ............................................................................ 107.03 Cap 40 mg ............................................................................ 107.03 Cap 60 mg ............................................................................ 107.03 Cap 80 mg ............................................................................ 139.11 Cap 100 mg .......................................................................... 139.11

127

20 20 20 20 28 28 28 28 28 28 28

✔ Oxydone BNM ✔ Oxydone BNM ✔ Oxydone BNM ✔ Oxydone BNM

145

✔ Strattera ✔ Strattera ✔ Strattera ✔ Strattera ✔ Strattera ✔ Strattera ✔ Strattera

➽ SA14160951 Special Authority for Subsidy Initial application from any relevant practitioner. Approvals valid for 6 months for applications meeting the following criteria: All of the following: 1 Patient has ADHD (Attention Deficit and Hyperactivity Disorder) diagnosed according to DSM-IV or ICD 10 criteria; and 2 Once-daily dosing; and 3 Any of the following: 3.1 Treatment with a subsidised formulation of a stimulant has resulted in the development or worsening of serious adverse reactions or where the combination of subsidised stimulant treatment with another agent would pose an unacceptable medical risk; or 3.2 Treatment with a subsidised formulation of a stimulant has resulted in worsening of co-morbid substance abuse or there is a significant risk of diversion with subsidised stimulant therapy; or continued...

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

21


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions – effective 1 February 2014 (continued)

continued... 3.3 An effective dose of a subsidised formulation of a stimulant has been trialled and has been discontinued because of inadequate clinical response; or 3.4 Treatment with a subsidised formulation of a stimulant is considered inappropriate because the patient has a history of psychoses or has a first-degree relative with schizophrenia; and 4 The patient will not be receiving treatment with atomoxetine in combination with a subsidised formulation of a stimulant, except for the purposes of transitioning from subsidised stimulant therapy to atomoxetine.

Renewal from any relevant practitioner. Approvals valid for 2 years where the treatment remains appropriate and the patient is benefiting from treatment. Note: A “subsidised formulation of a stimulant” refers to currently subsidised methylphenidate hydrochloride tablet formulations (immediate-release, sustained-release and extended-release) or dexamphetamine sulphate tablets. 166 MYCOPHENOLATE MOFETIL – Special Authority see SA1041 – Retail pharmacy Dispensing pharmacy should check which brand to dispense with the prescriber if prescribed generically. Tab 500 mg – Brand switch fee payable (Pharmacode 24512189).................................................... 25.00 50 ✔ Cellcept Cap 250 mg – Brand switch fee payable (Pharmacode 2452189)...................................................... 25.00 100 ✔ Cellcept MAGNESIUM HYDROXIDE 8% MIXTURE Magnesium hydroxide paste 29% Methyl hydroxybenzoate Water MAGNESIUM HYDROXIDE (amendment to presentation description) Paste 29% .............................................................................. 22.61 275 g 1.5 g to 1,000 ml 770 ml 500 g ✔ PSM

197

198

Effective 1 January 2014

29 BLOOD KETONE DIAGNOSTIC TEST METER – Up to 1 meter available on a PSO Meter funded for the purposes of blood ketone diagnostics only. Patient has had one or more episodes of ketoacidosis and is at risk of future episodes or patient is on an insulin pump. Only one meter per patient will be subsidised every 5 years. Meter ...................................................................................... 40.00 1 ✔ Freestyle Optium CEFTRIAXONE SODIUM – Subsidy by endorsement (amendment to chemical name and presentation description) a) Up to 5 inj available on a PSO b) Subsidised only if prescribed for a dialysis or cystic fibrosis patient, or the treatment of gonorrhoea, or the treatment of pelvic inflammatory disease, or the treatment of suspected meningitis in patients who have a known allergy to penicillin, and the prescription or PSO is endorsed accordingly. Inj 500 mg vial .......................................................................... 2.70 1 ✔ Veracol 1.50 ✔ Ceftriaxone-AFT Inj 1 g vial ............................................................................... 10.49 5 ✔ Aspen Ceftriaxone 5.22 ✔ Ceftriaxone-AFT KETOCONAZOLE (addition of Section 29) Tab 200 mg – Retail pharmacy-Specialist ................................ 38.12 30 ✔ Nizoral S29 Prescriptions must be written by, or on the recommendation of, an infectious disease physician, clinical microbiologist, dermatologist, endocrinologist or oncologist

90

97

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

22

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions – effective 1 January 2014 (continued)

127 OXYCODONE HYDROCHLORIDE a) Only on a controlled drug form b) See prescribing guideline below c) No patient co-payment payable d) Safety medicine; prescriber may determine dispensing frequency Tab controlled-release 10 mg – Brand switch fee payable (Pharmacode 2451794) ............ 6.75 Tab controlled-release 20 mg – Brand switch fee payable (Pharmacode 2451794) .......... 11.50 Tab controlled-release 40 mg – Brand switch fee payable (Pharmacode 2451794) .......... 18.50 Tab controlled-release 80 mg – Brand switch fee payable (Pharmacode 2451794) .......... 34.00

20 20 20 20

✔ Oxydone BNM ✔ Oxydone BNM ✔ Oxydone BNM ✔ Oxydone BNM

159

ERLOTINIB HYDROCHLORIDE – Retail pharmacy - Specialist – Special Authority SA14111044 Tab 100 mg ....................................................................... 1,133.00 30 ✔ Tarceva Tab 150 mg ....................................................................... 1,700.00 30 ✔ Tarceva ➽ SA14111044 Special Authority for Subsidy Initial application only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 4 months for applications meeting the following criteria: All of the following: 1 Patient has advanced, unresectable, Non Small Cell Lung Cancer (NSCLC); and 2 Patient has documented disease progression following treatment with first line platinum based chemotherapy; and 3 Erlotinib is to be given for a maximum of 3 months. Either 1 All of the following: 1.1 Patient has locally advanced or metastatic, unresectable, non-squamous Non Small Cell Lung Cancer (NSCLC); and 1.2 There is documentation confirming that the disease expresses activating mutations of EGFR tyrosine kinase; and 1.3 Either 1.3.1 Patient is treatment naïve; or 1.3.2 Both: 1.3.2.1 Patient has documented disease progression following treatment with first line platinum based chemotherapy; and 1.3.2.2 Patient has not received prior treatment with gefitinib; and 1.4 Erlotinib is to be given for a maximum of 3 months, or 2 The patient received funded erlotinib prior to 31 December 2013 and radiological assessment (preferably including CT scan) indicates NSCLC has not progressed. Renewal application only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 6 months where radiological assessment (preferably including CT scan) indicates NSCLC has not progressed.

183

FLUTICASONE WITH SALMETEROL – Special Authority see SA1179 – Retail pharmacy Aerosol inhaler 50 mcg with salmeterol 25 mcg ....................... 37.48 120 dose OP Aerosol inhaler 125 mcg with salmeterol 25 mcg .................... 49.69 120 dose OP Powder for inhalation 100 mcg with salmeterol 50 mcg – No more than 2 dose per day ............................................ 37.48 60 dose OP Powder for inhalation 250 mcg with salmeterol 50 mcg – No more than 2 dose per day ............................................ 49.69 60 dose OP

✔ Seretide ✔ Seretide ✔ Seretide Accuhaler ✔ Seretide Accuhaler

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

23


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions – effective 1 January 2014 (continued)

190 190 190 BIMATOPROST – Retail pharmacy-Specialist (removal of restriction) ❋ Eye drops 0.03% ..................................................................... 18.50 LATANOPROST – Retail pharmacy-Specialist (removal of restriction) ❋ Eye drops 50 mcg per ml, 2.5 ml ............................................... 1.99 TRAVOPROST – Retail pharmacy-Specialist (removal of restriction) ❋ Eye drops 0.004% ................................................................... 19.50 3 ml OP ✔ Lumigan

2.5 ml OP ✔ Hysite 2.5 ml OP ✔ Travatan

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

24

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 February 2014

42 FERROUS SULPHATE ❋ Tab long-acting 325 mg (105 mg elemental) ( subsidy and  price) .......................................................... 2.06 ❋‡ Oral liq 30 mg (6 mg elemental) per 1 ml ( subsidy) .......................................................................... 10.28 COMPOUND ELECTROLYTES ( subsidy) Powder for oral soln – Up to 10 sach available on a PSO............ 0.90 UREA ( subsidy) ❋ Crm 10% .................................................................................. 1.65 (3.07) OXYTOCIN – Up to 5 inj available on a PSO ( subsidy) Inj 5 iu per ml, 1 ml ampoule ..................................................... 4.75 Inj 10 iu per ml, 1 ml ampoule ................................................... 5.98 PHENOXYMETHYLPENICILLIN (PENICILLIN V) ( subsidy) Grans for oral liq 125 mg per 5 ml ............................................. 1.64 a) Up to 200 ml available on a PSO b) Wastage claimable – see rule 3.3.2 Grans for oral liq 250 mg per 5 ml ............................................. 1.74 a) Up to 300 ml available on a PSO b) Up to 2 x the maximum PSO quantity for RFPP – see rule 5.2.6 c) Wastage claimable – see rule 3.3.2 LAMIVUDINE – Special Authority see SA1364 – Retail pharmacy ( subsidy) Tab 150 mg ............................................................................ 52.50 (153.60) PAROXETINE HYDROCHLORIDE ( price) ❋ Tab 20 mg ................................................................................ 1.44

30 500 ml 5 100 g OP

✔ Ferrograd ✔ Ferodan ✔ Electral

50 70

Nutraplus 5 5 100 ml 100 ml

79

✔ Syntocinon ✔ Syntocinon ✔ AFT

93

✔ AFT

108

60 3TC 30 ✔ Loxamine

129

Effective 1 January 2014

46 63 ASPIRIN ( subsidy) ❋ Tab 100 mg ............................................................................ 10.50 BOSENTAN – Special Authority see SA0967 – Retail pharmacy ( subsidy) Tab 62.5 mg ...................................................................... 1,500.00 Tab 125 mg ....................................................................... 1,500.00 ETHINYLOESTRADIOL WITH LEVONORGESTREL ( subsidy) ❋ Tab 20 mcg with levonorgestrel 100 mcg and 7 inert tab – Up to 84 tab available on a PSO .......................................... 2.65 ❋ Tab 30 mcg with levonorgestrel 150 mcg and 7 inert tab – Up to 84 tab available on a PSO .......................................... 2.30 SODIUM CITRO-TARTRATE ( subsidy) ❋ Grans eff 4 g sachets ................................................................ 3.93 990 60 60 ✔ Ethics Aspirin EC ✔ pms-Bosentan ✔ pms-Bosentan

77

84 84 28

✔ Ava 20 ED ✔ Ava 30 ED ✔ Ural

81

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

25


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer's Price – effective 1 January 2014 (continued)

93 PHENOXYMETHYLPENICILLIN (PENICILLIN V) ( subsidy) Cap potassium salt 250 mg – Up to 30 cap available on a PSO ....................................... 11.99 Cap potassium salt 500 mg ..................................................... 14.45 a) Up to 20 cap available on a PSO b) Up to 2 x the maximum PSO quantity for RFPP – see rule 5.2.6 NYSTATIN ( price) Tab 500,000 u ........................................................................ 14.16 (17.09) Cap 500,000 u ........................................................................ 12.81 (15.47) IBUPROFEN ( subsidy) ❋‡ Oral liq 20 mg per ml............................................................... 1.89 ASPIRIN ( subsidy) ❋ Tab dispersible 300 mg – Up to 30 tab available on a PSO .............................................. 2.55 PAROXETINE HYDROCHLORIDE ( subsidy) ❋ Tab 20 mg ................................................................................ 1.44 (2.38) Note: Loxamine tab 20 mg, 90 tab packsize, remains fully subsidised. ONDANSETRON ( subsidy) ❋ Tab 4 mg ( price) .................................................................... 3.31 ❋ Tab 8 mg ................................................................................. 1.24 (1.70) 141

50 50

✔ Cilicaine VK ✔ Cilicaine VK

97

50 Nilstat 50 Nilstat 200 ml ✔ Fenpaed

114 124

100 30

✔ Ethics Aspirin

129

Loxamine

136

30 10

✔ Dr Reddy’s Ondansetron Dr Reddy’s Ondansetron

ALPRAZOLAM – Safety medicine; prescriber may determine dispensing frequency ( subsidy) Tab 500 mcg............................................................................. 3.25 50 (4.10) Arrow-Alprazolam ‡ Safety cap for extemporaneously compounded oral liquid preparations. LORAZEPAM – Safety medicine; prescriber may determine dispensing frequency ( subsidy) Tab 1 mg ................................................................................ 19.82 250 ✔ Ativan ‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 2.5 mg ............................................................................. 13.49 100 ✔ Ativan ‡ Safety cap for extemporaneously compounded oral liquid preparations. ERLOTINIB – Retail pharmacy-Specialist – Special Authority SA1411 ( subsidy) Tab 100 mg ....................................................................... 1,133.00 30 Tab 150 mg ....................................................................... 1,700.00 30 AZATHIOPRINE – Retail pharmacy-Specialist ( subsidy) ❋ Inj 50 mg .............................................................................. 126.00 1

142

159

✔ Tarceva ✔ Tarceva

165

✔ Imuran

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

26

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Section I

Effective 1 January 2014

225 INFLUENZA VACCINE – Hospital pharmacy [Xpharm] Inj 45 mcg in 0.5 ml syringe ................................................... 90.00 10 ✔ Influvac

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

27


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 February 2014

24 41 87 DIPHENOXYLATE HYDROCHLORIDE WITH ATROPINE SULPHATE ❋ Tab 2.5 mg with atropine sulphate 25 mcg ................................ 3.90 CALCITRIOL ❋‡ Oral liq 1 mcg per ml ............................................................. 39.40 LEUPRORELIN Inj 3.75 mg ........................................................................... 221.60 Inj 11.25 mg ......................................................................... 591.68 100 10 ml OP 1 1 ✔ Diastop ✔ Rocaltrol solution ✔ Lucrin Depot ✔ Lucrin Depot

111

INTERFERON ALFA-2A – PCT – Retail pharmacy-Specialist a) See prescribing guideline b) Prescriptions must be written by, or on the recommendation of, an internal medicine physician or ophthalmologist Inj 6 m iu prefilled syringe ........................................................ 62.64 1 ✔ Roferon-A Inj 9 m iu prefilled syringe ........................................................ 93.96 1 ✔ Roferon-A QUETIAPINE – Safety medicine; prescriber may determine dispensing frequency Tab 100 mg ............................................................................ 14.00 60 Note – Dr Reddy’s Quetiapine tab 100 mg in the 90 pack size remains subsidised. ✔ Dr Reddy’s Quetiapine

138

156

DOCETAXEL – PCT only – Specialist Inj 20 mg ................................................................................ 48.75 Inj 80 mg .............................................................................. 195.00

1 1

✔ Docetaxel Ebewe ✔ Docetaxel Ebewe ✔ Myaccord Ceptolate Ceptolate ✔ Myaccord ✔ Chloromycetin

166

MYCOPHENOLATE MOFETIL – Special Authority see SA1041 – Retail pharmacy Tab 500 mg ............................................................................ 25.00 50 (60.00) Cap 250 mg ............................................................................ 12.50 50 (30.00) 25.00 100 CHLORAMPHENICOL Ear drops 0.5%.......................................................................... 2.20 Note – Chloramphenicol eye drops 0.5% are subsidised for use in the ear. PHARMACY SERVICES ❋ Brand switch fee........................................................................ 4.33 5 ml OP

188

192 214

1 fee

✔ BSF Oxydone BNM

ORAL FEED 2 KCAL/ML – Special Authority see SA1195 – Hospital pharmacy [HP3] Additional subsidy by endorsement is available for patients being bolus fed through a feeding tube, or who have severe epidermolysis bullosa. The prescription must be endorsed accordingly. Liquid (vanilla) – Higher subsidy of $2.25 per 237 ml with Endorsement ................................................................. 1.14 237 ml OP (2.25) Two Cal HN Note – Two Cal HN 200 ml OP packsize remains subsidised.

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

28

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items – effective 1 January 2014

41 ASCORBIC ACID a) No more than 100 mg per dose b) Only on a prescription ❋ Tab 100 mg .............................................................................. 7.00 VITAMIN B COMPLEX ❋ Tab, strong, BPC ....................................................................... 4.30 VITAMINS ❋ Tab (BPC cap strength) ............................................................. 7.60 CHLORTALIDONE [CHLORTHALIDONE] ❋ Tab 25 mg ................................................................................ 4.80 MAGNESIUM SULPHATE ❋ Paste ........................................................................................ 2.98 (4.90)

500 500 1,000 30 80 g

✔ Vitala-C ✔ B-PlexADE ✔ MultiADE ✔ Igroton S29

41 41 59 75

PSM

84

OESTROGENS – See prescribing guideline ❋ Conjugated, equine tab 300 mcg ............................................... 3.01 28 (11.48) Premarin ❋ Conjugated, equine tab 625 mcg ............................................... 4.12 28 (11.48) Premarin Note: The old Pharmacodes are being delisted; Pharmacodes 2427478 and 2427486 will remain fully funded. AMOXYCILLIN Drops 125 mg per 1.25 ml ........................................................ 4.00 30 ml OP ✔ Ospamox Paediatric Drops

92 95

LINCOMYCIN – Retail pharmacy-Specialist Prescriptions must be written by, or on the recommendation of, an infectious disease physician or a clinical microbiologist Inj 300 mg per ml, 2 ml ........................................................... 80.00 5 ✔ Lincocin GABAPENTIN – Special Authority see SA1071– Retail pharmacy ▲ Cap 400 mg ............................................................................ 14.75 100 ✔ Nupentin Note: This is the blister pack presentation only. The Nupentin capsules in the bottle will remain fully funded. OXYCODONE HYDROCHLORIDE a) Only on a controlled drug form b) See prescribing guideline c) No patient co-payment payable d) Safety medicine; prescriber may determine dispensing frequency Tab controlled-release 10 mg .................................................... 6.75 (11.14) Tab controlled-release 20 mg .................................................. 11.50 (18.93) Tab controlled-release 40 mg .................................................. 18.50 (33.29) Tab controlled-release 80 mg .................................................. 34.00 (58.03) INFLUENZA VACCINE – HOSPITAL PHARMACY [XPHARM] Inj ........................................................................................... 90.00

131

127

20 OxyContin 20 OxyContin 20 OxyContin 20 OxyContin 10 ✔ Fluvax

225

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

29


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 February 2014

187 PHARMACY SERVICES ❋ Brand switch fee........................................................................ 4.33 1 fee ✔ BSF Oxydone BNM

Effective 1 April 2014

129 PAROXETINE HYDROCHLORIDE ❋ Tab 20 mg ................................................................................ 1.44 Note: Loxamine tab 20 mg, 90 tab packsize, remains fully subsidised. ONDANSETRON ❋ Tab 4 mg .................................................................................. 3.31 ❋ Tab 8 mg .................................................................................. 1.24 (1.70) 137 30 ✔ Loxamine

136

30 10

✔ Dr Reddy’s Ondansetron Dr Reddy’s Ondansetron

ALPRAZOLAM – Safety medicine; prescriber may determine dispensing frequency ( subsidy) Tab 250 mcg............................................................................. 2.50 50 ✔ Arrow-Alprazolam ‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 500 mcg............................................................................. 3.25 50 (4.10) Arrow-Alprazolam ‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 1 mg............................................................................... 5.00 50 ✔ Arrow-Alprazolam ‡ Safety cap for extemporaneously compounded oral liquid preparations.

Effective 1 May 2014

50 COMPOUND ELECTROLYTES Powder for oral soln – Up to 10 sach available on a PSO............ 0.90 UREA ❋ Crm 10% ................................................................................... 1.65 (3.07) OXYTOCIN – Up to 5 inj available on a PSO Inj 5 iu per ml, 1 ml ampoule ..................................................... 4.75 Inj 10 iu per ml, 1 ml ampoule ................................................... 5.98 LAMIVUDINE – Special Authority see SA1364 – Retail pharmacy Tab 150 mg ............................................................................ 52.50 (153.60) PHARMACY SERVICES ❋ Brand switch fee........................................................................ 4.33 5 ✔ Electral

70

100 g OP Nutraplus 5 5 60 3TC 1 fee ✔ BSF Cellcept

79

✔ Syntocinon ✔ Syntocinon

108

192

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

30

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Effective 1 July 2014

37 PANCREATIC ENZYME Cap EC 25,000 BP u lipase, 18,000 BP u amylase, 1,000 BP u protease ............................................................ 94.38

100

✔ Creon Forte

Effective 1 August 2014

25 MESALAZINE Suppos 1 g ............................................................................. 50.96 Note – The 30 suppos packsize remains subsidised. 28 ✔ Pentasa

42

FERROUS SULPHATE ❋ Tab long-acting 325 mg (105 mg elemental).............................. 5.06 150 (15.58) Ferrograd Note – Ferrograd tab long-acting 325 mg (105 mg elemental) 30 tab packsize remains subsidised. SPIRONOLACTONE ❋ Tab 25 mg ................................................................................ 3.65 ISOSORBIDE MONONITRATE ❋ Tab long-acting 40 mg .............................................................. 7.50 CICLOPIROX OLAMINE a) Only on a prescription b) Not in combination Soln 1% .................................................................................... 4.36 (11.54) 100 30

59 61 66

✔ Spirotone ✔ Corangin

20 ml OP Batrafen

138 208

OLANZAPINE – Safety medicine; prescriber may determine dispensing frequency Tab 2.5 mg ............................................................................... 2.00 28

✔ Olanzine

ORAL ELEMENTAL FEED 0.8KCAL/ML – Special Authority see SA1377 – Hospital pharmacy [HP3] Liquid (grapefruit) ...................................................................... 9.50 250 ml OP ✔ Elemental 028 Extra Liquid (pineapple & orange) ....................................................... 9.50 250 ml OP ✔ Elemental 028 Extra Liquid (summer fruit) ................................................................. 9.50 250 ml OP ✔ Elemental 028 Extra

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

31


Index

Pharmaceuticals and brands Symbols 3TC ............................................................. 25, 30 A Acipimox ........................................................... 19 Alprazolam ................................................... 26, 30 Amoxycillin .................................................. 19, 29 Apo-Amoxi......................................................... 19 Apo-Cilazapril/Hydrochlorothiazide ..................... 19 Arrow-Alprazolam ........................................ 26, 30 Arrow-Fluoxetine ................................................ 18 Ascorbic acid ..................................................... 29 Aspen Ceftriaxone .............................................. 22 Aspirin ......................................................... 25, 26 Ativan ................................................................ 26 Atomoxetine ....................................................... 21 Ava 20 ED.......................................................... 25 Ava 30 ED.......................................................... 25 Azathioprine ....................................................... 26 B Baclofen ............................................................ 18 Batrafen ............................................................. 31 Bimatoprost ....................................................... 24 Blood ketone diagnostic test meter ..................... 22 Bosentan ........................................................... 25 B-PlexADE ......................................................... 29 BSF Cellcept ................................................ 18, 30 BSF Oxydone BNM ................................. 20, 28, 30 C Calcitriol ............................................................ 28 Carbimazole ....................................................... 19 Cardizem CD ...................................................... 19 Ceftriaxone................................................... 19, 22 Ceftriaxone-AFT ........................................... 19, 22 Cellcept ............................................................. 22 Ceptolate ........................................................... 28 Chloramphenicol ................................................ 28 Chloromycetin.................................................... 28 Chlortalidone [chlorthalidone] ............................. 29 Ciclopirox olamine.............................................. 31 Cilazapril with hydrochlorothiazide ...................... 19 Cilicaine VK........................................................ 26 Compound electrolytes................................. 25, 30 Corangin ............................................................ 31 Creon 25000...................................................... 19 Creon Forte ........................................................ 31 D Dexamethasone-hameln ............................... 18, 21 Dexamethasone phosphate........................... 18, 21 Diastop .............................................................. 28 Diltiazem hydrochloride ...................................... 19 Dimethicone....................................................... 18 Diphenoxylate hydrochloride with atropine sulphate .................................... 28 Docetaxel ........................................................... 28 Docetaxel Ebewe ................................................ 28 Dr Reddy’s Ondansetron .............................. 26, 30 Dr Reddy’s Quetiapine ........................................ 28 E Electral ........................................................ 25, 30 Elemental 028 Extra ..................................... 18, 31 Eltrombopag ...................................................... 19 Erlotinib ....................................................... 23, 26 Ethics Aspirin ..................................................... 26 Ethics Aspirin EC................................................ 25 Ethinyloestradiol with levonorgestrel ................... 25 F Fenpaed ............................................................. 26 Ferodan ....................................................... 21, 25 Ferrograd ..................................................... 25, 31 Ferrous sulphate .................................... 21, 25, 31 Fluoxetine hydrochloride ..................................... 18 Fluticasone with salmeterol ................................ 23 Fluvax ................................................................ 29 Freestyle Optium ................................................ 22 G Gabapentin ........................................................ 29 H healthE Dimethicone 5% ..................................... 18 Hysite ................................................................ 24 I Ibuprofen ........................................................... 26 Igroton ............................................................... 29 Imuran ............................................................... 26 Influenza vaccine.......................................... 27, 29 Influvac .............................................................. 27 Interferon alfa-2a................................................ 28 Ismo 40 Retard .................................................. 18 Isosorbide mononitrate................................. 18, 31 K Ketoconazole ..................................................... 22 L Lamivudine .................................................. 25, 30 Latanoprost........................................................ 24 Leuprorelin......................................................... 28 Lincocin ............................................................. 29 Lincomycin ........................................................ 29 Lioresal Intrathecal ............................................. 18 Lorazepam ......................................................... 26 Loxamine ............................................... 25, 26, 30 Lucrin Depot ...................................................... 28

32


Index

Pharmaceuticals and brands Lumigan ............................................................ 24 M Magnesium hydroxide ........................................ 22 Magnesium hydroxide 8% mixture ...................... 22 Magnesium sulphate .......................................... 29 Mesalazine ......................................................... 31 MultiADE............................................................ 29 Myaccord .......................................................... 28 Mycophenolate mofetil ................................. 22, 28 N Nilstat ................................................................ 26 Nizoral ............................................................... 22 Nupentin ............................................................ 29 Nutraplus ..................................................... 25, 30 Nystatin ............................................................. 26 O Oestrogens ........................................................ 29 Olanzapine ......................................................... 31 Olanzine ............................................................. 31 Olbetam s29 ...................................................... 19 Ondansetron ................................................ 26, 30 Oral elemental feed 0.8 kcal/ml..................... 18, 31 Oral feed 2 kcal/ml ............................................. 28 Ospamox Paediatric Drops ................................. 29 Oxycodone hydrochloride ....................... 21, 23, 29 OxyContin .......................................................... 29 Oxydone BNM .............................................. 21, 23 Oxytocin ...................................................... 25, 30 P Pancreatic enzyme ....................................... 19, 31 Paroxetine hydrochloride ........................ 25, 26, 30 Pentasa ............................................................. 31 Pharmacy services........................... 18, 20, 28, 30 Phenoxymethylpenicillin (penicillin v) ............ 25, 26 pms-Bosentan ................................................... 25 Premarin ............................................................ 29 Q Quetiapine.......................................................... 28 R Revolade............................................................ 19 Rocaltrol solution ............................................... 28 Roferon-A .......................................................... 28 S Seretide ............................................................. 23 Seretide Accuhaler ............................................. 23 Sodium citro-tartrate .......................................... 25 Spironolactone ................................................... 31 Spirotone ........................................................... 31 Strattera ............................................................. 21 Syntocinon................................................... 25, 30 T Tarceva........................................................ 23, 26 Travatan............................................................. 24 Travoprost ......................................................... 24 Two Cal HN........................................................ 28 U Ural.................................................................... 25 Urea............................................................. 25, 30 V Veracol .............................................................. 22 Vitala-C .............................................................. 29 Vitamin B complex ............................................. 29 Vitamins ............................................................ 29

33


Index

Pharmaceuticals and brands

34


Pharmaceutical Management Agency Level 9, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50 ISSN 1172-9376 (Print) ISSN 1179-3686 (Online)

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update.

If Undelivered, Return To: PO Box 10-254, Wellington 6143, New Zealand

Metadata

Title

Schedule Update - effective 1 February 2014

Abstract

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 February 2014 Cumulative for January and February 2014 Contents Summary of PHARMAC decisions effective 1 February 2014 …. 3 Fluoxetine tender transition ….. 4 Ferrous sulphate (Ferrograd) tab long-acting 325…

Page 1

icon

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.